ALNYLAM PHARMACEUTICALS INC (ALNY) Stock Cash Flow
NASDAQ:ALNY - Nasdaq - US02043Q1076 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -269.70M | -278.16M | -440.24M | -1.13B | -852.80M | |||
| Depreciation Amortization | 57.56M | 56.67M | 54.05M | 44.50M | 47.60M | |||
| Income Taxes - Deferred | N/A | -106.76M | N/A | N/A | N/A | |||
| Change In Working Capital | -309.83M | -214.08M | 10.76M | -35.60M | -162.80M | |||
| Interest Paid | 103.57M | 67.58M | 32.12M | 45.20M | 24.70M | |||
| Taxes Paid | N/A | 14.36M | N/A | N/A | N/A | |||
| Other non cash items | 573.99M | 534.02M | 479.58M | 581.00M | 326.40M | |||
| OPERATING CASH FLOW | -45.11M | -8.31M | 104.16M | -541.30M | -641.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -30.27M | -34.28M | -62.21M | -72.10M | -76.40M | |||
| Other Investing Activity | 94.82M | -82.56M | -274.14M | 241.40M | -196.90M | |||
| INVESTING CASH FLOW | 64.55M | -116.84M | -336.35M | 169.40M | -273.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | 135.40M | 500.00M | |||
| Stock Issued/Repurchased | 326.46M | 302.95M | 147.46M | 259.40M | 246.30M | |||
| Other Financing Activity | -17.13M | -8.79M | 24.67M | 31.00M | 500.90M | |||
| FINANCING CASH FLOW | 309.33M | 294.16M | 172.13M | 425.80M | 1.25B | |||
| Exchange Rate Effect | 8.76M | -15.24M | 6.39M | -7.40M | -9.00M | |||
| CHANGE IN CASH | 337.53M | 153.77M | -53.67M | 46.50M | 323.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -45.11M | -8.31M | 104.16M | -541.30M | -641.70M | |||
| Capital Expenditure | -30.27M | -34.28M | -62.21M | -72.10M | -76.40M | |||
| FREE CASH FLOW | -75.39M | -42.59M | 41.95M | -613.40M | -718.10M | |||
All data in USD